Efficient bloodless mechanical thrombectomy for massive dural sinus thrombosis associated with COVID-19 using the 12-French Penumbra Lightning intelligent aspiration system.

Endovascular treatment for dural sinus thrombosis is typically reserved for a small subset of patients who fail medical management. Conventional neurovascular aspiration catheters are suboptimal for use in dural sinus thrombosis given their relatively small caliber with respect to the large dural sinuses and risk of significant blood loss if continuous suction is applied through the catheter as it traverses patent portions of the large veins. We present a case where the Penumbra Lightning aspiration system, currently approved for thrombectomy in the peripheral and pulmonary vasculature, was successfully used for dural sinus thrombectomy with rapid clinical improvement of the patient.

Neuroendovascular Treatment of Acute Stroke During COVID-19: A Guide From the Frontlines.

Since the initial reports surfaced of a novel coronavirus causing illness and loss of life in Wuhan, China, COVID-19 has rapidly spread across the globe, infecting millions and leaving hundreds and thousands dead. As hospitals cope with the influx of patients with COVID-19, new challenges have arisen as health-care systems care for patients with COVID-19 while still providing essential emergency care for patients with acute strokes and acute myocardial infarction. Adding to this complex scenario are new reports that patients with COVID-19 are at increased risk of thromboembolic complications including strokes. In this article, we detail our experience caring for acute stroke patients and provide some insight into neurointerventional workflow modifications that have helped us adapt to the COVID-19 era.